Samsara Bio Capital, LLC Hookipa Pharma Inc. Transaction History

Samsara Bio Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 18, 2021	SELL	$10.64 - $14.7 $1.38 Million - $1.91 Million	-129,660 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$9.32 - $13.63 $121,700 - $177,980	13,058 Added 11.2%	129,660 $1.44 Million
Q3 2020 Nov 16, 2020	SELL	$8.59 - $11.89 $2.44 Million - $3.37 Million	-283,643 Reduced 70.87%	116,602 $1.1 Million
Q2 2020 Aug 14, 2020	SELL	$7.23 - $12.1 $939,900 - $1.57 Million	-130,000 Reduced 24.52%	400,245 $4.65 Million
Q2 2019 Aug 14, 2019	BUY	$6.16 - $14.15 $3.27 Million - $7.5 Million	530,245 New	530,245 $3.57 Million

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $111M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.